Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse.
Acetaldehyde, the end product of oxidative ethanol metabolism, contributes to alcohol-induced disease in the liver, but cannot account for damage in organs such as the pancreas, heart, or brain, where oxidative metabolism is minimal or absent; nor can it account for the varied patterns of organ damage found in chronic alcoholics. Thus other biochemical mediators may be important in the pathogenesis of alcohol-induced organ damage. Many human organs were found to metabolize ethanol through a recently described nonoxidative pathway to form fatty acid ethyl esters. Organs lacking oxidative alcohol metabolism yet frequently damaged by ethanol abuse have high fatty acid ethyl ester synthetic activities and show substantial transient accumulations of fatty acid ethyl esters. Thus nonoxidative ethanol metabolism in addition to the oxidative pathway may be important in the pathophysiology of ethanol-induced disease in humans.
D000273:Adipose Tissue / Q000378:metabolism; D000437:Alcoholism / Q000378:metabolism*; D001711:Biotransformation; D001921:Brain / Q000378:metabolism; D000431:Ethanol / Q000378:metabolism*; D006801:Humans; D008099:Liver / Q000378:metabolism; D008297:Male; D009132:Muscles / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D009829:Oleic Acids / Q000096:biosynthesis; D009928:Organ Specificity; D010084:Oxidation-Reduction; D010179:Pancreas / Q000378:metabolism; D013737:Testis / Q000378:metabolism
D009829:Oleic Acids; D000431:Ethanol; C033180:ethyl oleate